[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
November 1973

Elastosis Perforans Serpiginosa During Penicillamine Therapy for Wilson Disease

Author Affiliations

New York

From the divisions of dermatology and genetic medicine, Department of Medicine (Drs. Pass, Sternlieb, and Scheinberg) and Department of Pathology (Dr. Goldfischer), and Albert Einstein College of Medicine, and the Bronx Municipal Hospital Center, New York. Dr. Pass is now with the University of Minnesota Hospital, Minneapolis.

Arch Dermatol. 1973;108(5):713-715. doi:10.1001/archderm.1973.01620260061026

Elastosis perforans serpiginosa (EPS) developed in three patients with Wilson disease who underwent prolonged treatment with penicillamine. The patients' clinical courses and histopathological findings were identical to those of EPS, as described in the literature. Because EPS has not been reported to occur in untreated patients with Wilson disease, penicillamine appears to be the causative factor. The lesions may represent a direct interaction of penicillamine with elastin, or they may be the indirect effect of a local copper deficiency.